×
About 88 results

ALLMedicine™ Acute Erythroid Leukemia Center

Research & Reviews  34 results

Erythroleukemia: an Update.
https://doi.org/10.1007/s11912-021-01060-8
Current Oncology Reports; Weinberg OK, Arber DA

Apr 21st, 2021 - Acute erythroleukemia (AEL) is a rare form of acute myeloid leukemia recognized by erythroblastic proliferation. Many controversies remain around diagnosis influencing prognostic and therapeutic implications relating to this unique leukemia subset...

Modeling acute erythroid leukemia via CRISPR.
https://doi.org/10.1182/blood.2020010544
Blood Zhang JP, Cheng T

Mar 26th, 2021 - Modeling acute erythroid leukemia via CRISPR.|2021|Zhang JP,Cheng T,|

Modeling and targeting of erythroleukemia by hematopoietic genome editing.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995291
Blood Iacobucci I, Qu C et. al.

Jan 30th, 2021 - Acute erythroid leukemia (AEL) is characterized by a distinct morphology, mutational spectrum, lack of preclinical models, and poor prognosis. Here, using multiplexed genome editing of mouse hematopoietic stem and progenitor cells and transplant a...

Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future.
https://doi.org/10.2174/1566524021666210121142316
Current Molecular Medicine; Liao Z, Li J et. al.

Jan 22nd, 2021 - Acute erythroid leukemia (AEL) is a subtype of acute myeloid leukemia (AML) with features such as accumulation of maturation-arrested erythroblasts. Compared with AML, the progression of AEL is faster and the prognosis to available therapy is wors...

Acute Myeloid Leukemia (AML) Staging
https://emedicine.medscape.com/article/2006750-print

Dec 30th, 2020 - Two staging systems are commonly used for acute myeloid leukemia (AML). The French-American-British (FAB) classification system is based on morphology to define specific immunotypes. The World Health Organization (WHO) classification reviews chrom...

see more →

Clinicaltrials.gov  1 results

Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing
https://clinicaltrials.gov/ct2/show/NCT02861651

Aug 10th, 2016 - Acute erythroid leukemia (AEL) is a morphologically distinct, infrequent (o5%) acute myeloid leukemia (AML) designed as M6 in the French- American-British (FAB) classification. The World Health Organization classification recognizes two subclasses...

see more →